Education
About Us
Working with TipRanks
Follow Us
SI-Bone Inc (SIBN)
NASDAQ:SIBN
SIBN Stock Chart & Stats
$20.88
$0.02(0.14%)
At close: 4:00 PM EST
$20.88
$0.02(0.14%)
Day’s Range― - ―
52-Week Range$12.50 - $21.89
Previous CloseN/A
Volume50.81K
Average Volume (3M)648.60K
Market Cap
$906.01M
Enterprise Value$526.83M
Total Cash (Recent Filing)$145.74M
Total Debt (Recent Filing)$36.84M
Price to Earnings (P/E)―
Beta0.66
Next Earnings
Mar 02, 2026EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding43,391,254
10 Day Avg. Volume524,959
30 Day Avg. Volume648,599
Financial Highlights & Ratios
PEG Ratio0.56
Price to Book (P/B)3.48
Price to Sales (P/S)3.48
P/FCF Ratio-25.36
Enterprise Value/Market Cap0.58
Enterprise Value/Revenue2.72
Enterprise Value/Gross Profit3.42
Enterprise Value/Ebitda-38.68
Forecast
1Y Price Target
$25.17Price Target Upside20.55% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Product LaunchesUpcoming product launches could result in active surgeon adoption across SIBN's portfolio to drive utilization higher.
ProfitabilitySIBN can deliver potential upside to estimates, which should drive increasing profitability.
ValuationSIBN's valuation is considered attractive with its EV/sales multiple below its trailing three-year average.
Bears Say
SI-Bone News
SIBN FAQ
What was SI-Bone Inc’s price range in the past 12 months?
SI-Bone Inc lowest stock price was $12.49 and its highest was $21.89 in the past 12 months.
What is SI-Bone Inc’s market cap?
SI-Bone Inc’s market cap is $906.01M.
When is SI-Bone Inc’s upcoming earnings report date?
SI-Bone Inc’s upcoming earnings report date is Mar 02, 2026 which is in 50 days.
How were SI-Bone Inc’s earnings last quarter?
SI-Bone Inc released its earnings results on Nov 10, 2025. The company reported -$0.11 earnings per share for the quarter, beating the consensus estimate of -$0.166 by $0.056.
Is SI-Bone Inc overvalued?
According to Wall Street analysts SI-Bone Inc’s price is currently Undervalued.
Does SI-Bone Inc pay dividends?
SI-Bone Inc does not currently pay dividends.
What is SI-Bone Inc’s EPS estimate?
SI-Bone Inc’s EPS estimate is -0.12.
How many shares outstanding does SI-Bone Inc have?
SI-Bone Inc has 43,391,254 shares outstanding.
What happened to SI-Bone Inc’s price movement after its last earnings report?
SI-Bone Inc reported an EPS of -$0.11 in its last earnings report, beating expectations of -$0.166. Following the earnings report the stock price went up 16.199%.
Which hedge fund is a major shareholder of SI-Bone Inc?
Currently, no hedge funds are holding shares in SIBN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
SI-Bone Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$25.17 (20.55% Upside)
$25.17 (20.55% Upside)
Blogger Sentiment
Bullish
SIBN Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 168.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $599.1K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
54.93%
12-Months-Change
Fundamentals
Return on Equity
-12.91%
Trailing 12-Months
Asset Growth
3.20%
Trailing 12-Months
Company Description
SI-Bone Inc
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fractures. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; and iFuse-TORQ, a set of 3D-printed threaded implants designed to treat fractures of the pelvis and for minimally invasive sacroiliac joint fusion. It markets its products primarily with a direct sales force, as well as through distributors. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
SIBN Company Deck
SIBN Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
SI-BONE, Inc. delivered strong revenue growth and achieved significant milestones in profitability and physician engagement. While there are challenges in terms of net loss and operating expenses, the company's growth trajectory, product pipeline, and operational improvements present a positive outlook.View all SIBN earnings summariesSIBN Stock 12 Month Forecast
Average Price Target
$25.17
▲(20.55% Upside)
Technical Analysis
Ownership Overview
4.84% Insiders
27.29% Mutual Funds
39.17% Other Institutional Investors
18.20% Public Companies and
Individual Investors